24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Bristol-Myers Squib
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
16:52
While some tech giants cut jobs, Palo Alto Networks and Nvidia are hiring hundreds in Israel
15:09
The people saying goodbye to high-tech
14:04
“AI tools will not replace doctors, but they will save us work”
13:43
Maya Kadouri appointed Chief Strategy Officer at investment AI company BridgeWise
More stories
Buzz
Most popular
Daily
Weekly
1
Israel searches for technology that could find soldiers and pilots who cannot call for help
2
Another 10 U.S. tankers are headed to Israel's Ben Gurion as airport delays mount
3
ServiceNow continues layoffs as it restructures around AI
4
Israel's Iron Dome and Arrow makers unlikely to reach the IPO market before 2027 as Tomer joins the queue
5
After IAI and Rafael, secretive missile engine maker Tomer moves toward an IPO
More news
Bristol-Myers Squib
2 stories about Bristol-Myers Squib
Immunai and Bristol Myers Squibb turn to AI to decode immune responses in clinical trials
15.01.26
|
CTech
The collaboration aims to improve understanding of patient biology in clinical trials.
Bristol-Myers Squibb Invests $12 Million in Israeli Immunotherapy Company Compugen
12.10.18
|
Dror Reich
The investment is part of a clinical trial collaboration for a treatment that combines Compugen’s investigational antibody with an immune checkpoint inhibitor from Bristol-Myers Squibb